ReviewJournal of pharmacy & bioallied sciences2025
HMPV Virus Outbreak: First Review in Literature.
Review in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human metapneumovirus (HMPV), a pathogen within the Pneumoviridae family, is a notable contributor to respiratory tract infections worldwide. Identified in 2001, HMPV predominantly affects young children, the elderly, and individuals with compromised immune systems. The virus exhibits seasonal patterns, with infection rates typically increasing during late winter and spring. The virus spreads through respiratory droplets, leading to symptoms ranging from mild upper respiratory tract infections to severe lower respiratory illnesses such as bronchiolitis and pneumonia. Recent surges in HMPV cases, notably the 2024-2025 outbreak in China, have underscored the importance of understanding its epidemiology, transmission mechanisms, and clinical impact. Despite its clinical significance, there are currently no specific antiviral treatments or vaccines available for HMPV, making prevention strategies and supportive care essential components of management. This review provides a comprehensive overview of HMPV, including its virology, epidemiology, clinical manifestations, diagnostic methods, treatment options, and preventive measures, with a focus on recent outbreaks and their implications for public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.